Harris, Claire L.
Complement as a therapeutic target [electronic resource] / Claire Harris. - London : Henry Stewart Talks, 2017. - 1 online resource (1 streaming video file (43 min.) : color, sound). - Macular degeneration, 2056-452X The complement system, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Complement system. Henry Stewart talks. Biomedical & life sciences collection. Macular degeneration. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Physiological roles of complement -- Complement activation and control -- Complement-mediated disease -- The challenges of complement drug discovery -- Current drugs in the clinic, highlights and drawbacks -- Strategies for complement inhibition -- The current anti-complement drug development landscape.
Access restricted to subscribers.
Mode of access: World Wide Web.
4551 Henry Stewart Talks
Complement (Immunology)
Drug development.
Retinal degeneration--Treatment.
Clinical Trials, Phase III as Topic.
Complement Activation--drug effects.
Complement Activation--immunology.
Complement Inactivating Agents--immunology.
Complement Inactivating Agents--pharmacology.
Complement Inactivator Proteins--pharmacology.
Complement System Proteins--immunology.
Drug Design.
Drug Discovery.
eculizumab
Macular Degeneration--drug therapy.
Macular Degeneration--immunology.
Complement as a therapeutic target [electronic resource] / Claire Harris. - London : Henry Stewart Talks, 2017. - 1 online resource (1 streaming video file (43 min.) : color, sound). - Macular degeneration, 2056-452X The complement system, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Complement system. Henry Stewart talks. Biomedical & life sciences collection. Macular degeneration. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Physiological roles of complement -- Complement activation and control -- Complement-mediated disease -- The challenges of complement drug discovery -- Current drugs in the clinic, highlights and drawbacks -- Strategies for complement inhibition -- The current anti-complement drug development landscape.
Access restricted to subscribers.
Mode of access: World Wide Web.
4551 Henry Stewart Talks
Complement (Immunology)
Drug development.
Retinal degeneration--Treatment.
Clinical Trials, Phase III as Topic.
Complement Activation--drug effects.
Complement Activation--immunology.
Complement Inactivating Agents--immunology.
Complement Inactivating Agents--pharmacology.
Complement Inactivator Proteins--pharmacology.
Complement System Proteins--immunology.
Drug Design.
Drug Discovery.
eculizumab
Macular Degeneration--drug therapy.
Macular Degeneration--immunology.